These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34691002)

  • 1. Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617.
    Fan LQ; Hu XY; Chen YY; Peng XL; Fu YH; Zheng YP; Yu JM; He JS
    Front Microbiol; 2021; 12():750725. PubMed ID: 34691002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.
    Cherian S; Potdar V; Jadhav S; Yadav P; Gupta N; Das M; Rakshit P; Singh S; Abraham P; Panda S; Team N
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Characterization of an Emerging SARS-CoV-2 Variant During the Early Second Wave of the SARS-CoV-2 Pandemic in Maharashtra, India.
    Karyakarte RP; Das R; Joshi S; Jayaram A; Yanamandra S; Shende S; Taji N; Rane S; Bawale R; Chaudhari GP; Karekar B; Sakalkar SR; Tiwari RG; Jadhav MG
    Cureus; 2023 Nov; 15(11):e48604. PubMed ID: 38090396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
    Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
    Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
    Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
    Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India.
    Gopalan V; Chandran A; Arumugam K; Sundaram M; Velladurai S; Govindan K; Azhagesan N; Jeyavel P; Dhandapani P; Sivasubramanian S; Kitambi SS
    J Glob Infect Dis; 2023; 15(2):43-51. PubMed ID: 37469462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.
    Mertens J; Coppens J; Loens K; Le Mercier M; Xavier BB; Lammens C; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Clin Microbiol Infect; 2022 Jan; 28(1):124-129. PubMed ID: 34537361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
    Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity.
    Tsuchiya K; Yamamoto N; Hosaka Y; Wakita M; Hiki M; Matsushita Y; Mori H; Hori S; Misawa S; Miida T; Nojiri S; Takahashi K; Naito T; Tabe Y
    Front Microbiol; 2022; 13():912061. PubMed ID: 35966679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.